Emily Dutton

Dr. Emily Dutton

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
JWJenny Wilshaw
Jenny Wilshaw
SRSteven L. Rosenthal
Steven L. Rosenthal
GWGerhard Wess
Gerhard Wess
DDDave Dickson
Dave Dickson
LBLuca Bevilacqua
Luca Bevilacqua
ABAdrian Boswood
Adrian Boswood
Background: Treatment is indicated in dogs with preclinical degenerative mitral valve disease (DMVD) and cardiomegaly (stage B2). This is best diagnosed using echocardiography; however, relying upon this limits access to accurate diagnosis. Objectives: To evaluate whether cardiac biomarker concentrations can be used alongside other clinical data to identify stage B2 dogs. Animals: Client-owned dogs (n = 1887) with preclinical DMVD prospectively sampled in Germany, the United Kingdom, and the United States. Methods: Dogs that met inclusion criteria and were not receiving pimobendan (n = 1245) were used for model development. Explanatory (multivariable logistic regression) and predictive models were developed using clinical observations, biochemistry, and cardiac biomarker concentrations, with echocardiographically confirmed stage B2 disease as the outcome. Receiver operating characteristic curves assessed the ability to identify stage B2 dogs. Results: Age, appetite, serum alanine aminotransferase activity, body condition, serum creatinine concentration, murmur intensity, and plasma N-terminal propeptide of B-type natriuretic peptide (NT-proBNP) concentration were independently associated with the likelihood of being stage B2. The discriminatory ability of this explanatory model (area under curve [AUC], 0.84; 95% confidence interval [CI], 0.82-0.87) was superior to NT-proBNP (AUC, 0.77; 95% CI, 0.74-0.80) or the vertebral heart score alone (AUC, 0.76; 95% CI, 0.69-0.83). A predictive logistic regression model could identify the probability of being stage B2 (AUC test set, 0.86; 95% CI, 0.81-0.91). Conclusion and Clinical Importance: Our findings indicate accessible measurements could be used to screen dogs with preclinical DMVD. Encouraging at-risk dogs to seek further evaluation could result in a greater proportion of cases being appropriately managed.

17 April 2018 in Journal of Small Animal Practice
Verified
Journal Article
Closed access
PDF file
EDEmily Dutton
Emily Dutton
JLJ. López‐Alvarez
J. López‐Alvarez

7 February 2013 in Journal of Small Animal Practice
Verified
Journal Article
Closed access
PDF file
LML. Motta
L. Motta
EDEmily Dutton
Emily Dutton

1 February 2017 in Journal of Veterinary Cardiology
Verified
Journal Article
Closed access
EDEmily Dutton
Emily Dutton
JDJoanna Dukes-McEwan
Joanna Dukes-McEwan
PCP.J. Cripps
P.J. Cripps

10 September 2024 in Animals
Verified
Journal Article
Open access
PDF file
JSJoonbum Seo
Joonbum Seo
YLYvonne Loh
Yvonne Loh
DCDavid J Connolly
David J Connolly
VFVirginia Luis Fuentes
Virginia Luis Fuentes
EDEmily Dutton
Emily Dutton
JMJohn Munday
John Munday
Recently, hypertrophic cardiomyopathy (HCM) in Sphynx cats has been associated with a variant in the gene encoding Alström syndrome protein 1 (ALMS1). The primary aims of this study were to describe the prevalence of HCM in Sphynx cats in New Zealand, and to assess the association between HCM and the ALMS1 variant in this population. In this prospective study, 55 apparently healthy Sphynx cats from registered Sphynx breeders and pet owners in New Zealand were screened by a cardiologist. A total of 42 of these cats had a repeat cardiac examination after median 1.8 years (range: 1.6–2.2). The frequency of the ALMS1 variant was 70.9% (11 homozygous and 28 heterozygous). At the median age of 5.8 years (range: 2.4–13.1), the prevalence of HCM was 40% (20 out of 55 cats). Three cats with HCM died during the study with congestive heart failure. All three cats had focal but extensive myocardial ischemia or infarction at necropsy. The ALMS1 variant was not associated with the HCM diagnosis. In summary, HCM was common in the studied cohort, suggesting Sphynx cats are predisposed to this disease. While the ALMS1 variant was also frequently detected, it was not associated with HCM in this population.

1 April 2022 in Journal of Veterinary Cardiology
Verified
Journal Article
Closed access
EDEmily Dutton
Emily Dutton
PCP. Cripps
P. Cripps
SHS.A.F. Helps
S.A.F. Helps
JHJ. Harris
J. Harris
JDJ. Dukes-McEwan
J. Dukes-McEwan